Danny Houtsma
Haag, LI, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Pathway activity profiling can predict neoadjuvant endocrine therapy response in HR+ HER2- postmenopausal early stage breast cancer.
Journal: Breast cancer research : BCR
Published: July 31, 2025
Physical activity patterns after diagnosis and survival of prognostic colorectal cancer subgroups.
Journal: JNCI cancer spectrum
Published: July 23, 2025
Health economic outcomes and costs of CDK4/6 inhibitor use in first- versus second-line for advanced breast cancer: A cost-effectiveness analysis of the phase 3 SONIA trial.
Journal: European journal of cancer (Oxford, England : 1990)
Published: June 12, 2025
Cabazitaxel Versus Abiraterone or Enzalutamide for Poor-prognosis Metastatic Castration-resistant Prostate Cancer After Docetaxel: A Phase 2 Trial with a Circulating Tumor DNA Analysis.
Journal: European urology oncology
Published: April 30, 2025
PSA Secretion from Single Circulating Tumor Cells of Metastatic Castration-Naïve Prostate Cancer Patients.
Journal: Cancer research communications
Published: March 19, 2025
Ribociclib-Letrozole Combination as an Alternative for Neoadjuvant Chemotherapy in Selected Postmenopausal Patients with Luminal Breast Cancer (BOOG 2017-01).
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 15, 2024
DOSAGE study: protocol for a phase III non-inferiority randomised trial investigating dose-reduced chemotherapy for advanced colorectal cancer in older patients.
Journal: BMJ open
Published: August 14, 2024
Tolerability and effectiveness of palbociclib in older women with metastatic breast cancer.
Journal: Breast cancer research and treatment
Published: January 15, 2024
Determinants of Physical Activity among Patients with Colorectal Cancer: From Diagnosis to 5 Years after Diagnosis.
Journal: Medicine and science in sports and exercise
Published: December 11, 2023
Phase 1 Study to Evaluate the Safety of Reducing the Prophylactic Dose of Dexamethasone around Docetaxel Infusion in Patients with Prostate and Breast Cancer.
Journal: Cancers
Published: December 23, 2022
Efficacy, safety and biomarker analysis of durvalumab in patients with mismatch-repair deficient or microsatellite instability-high solid tumours.
Journal: BMC cancer
Published: December 20, 2022
Comparable effectiveness of 45- and 20-min post-infusion scalp cooling time in preventing paclitaxel-induced alopecia - a randomized controlled trial.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: March 11, 2022
Last Updated: 09/26/2026